Wellvana, Florence, Zorro
Value-based care enabler Wellvana clinches $84M to expand in existing, new markets
Wellvana Health, a value-based care technology company, nabbed $84 million in a series B round.
The investment was co-led by Heritage Group and Valtruis with participation from Memorial Hermann Health System. The round brings Wellvana’s total funding to approximately $140 million and will be used to support Wellvana’s continued growth in existing and new markets.
Founded in 2019, Wellvana serves physicians, home health agencies, skilled nursing facilities and health systems in 22 states. It reaches more than 100,000 lives through multiple payers, Medicare Advantage and three national contracts for the 2023 ACO REACH model.
Wellvana offers its clients data analytics and a population health platform, in-house clinicians and care coordinators, a coding and quality assurance auditing team, partner benefits focused on social drivers of health and other tools to close care gaps.
https://www.fiercehealthcare.com/finance/value-based-care-enabler-wellvana-clinches-84m-expand
Florence Raises $20M in Seed Funding
Florence, a New York-based provider of a healthcare enablement software platform, raised $20M in Seed funding.
The round was led by Thrive Capital, GV, Salesforce Ventures with participation from Vast Ventures, BoxGroup and Atento Capital.
The company intends to use the funds to accelerate growth, expand operations and its business reach.
Founded in 2021 by CEO Aniq Rahman, Florence is a health tech company that creates solutions across multiple sites of care, starting with emergency departments. Patients can track and accelerate their journey via smartphone, update clinical information, control prescription fulfillment, initiate self-discharge when appropriate, and schedule follow-up appointments.
The company is working with health systems and most recently launched with Luminis Health in Maryland.
Florence Raises $20M in Seed Funding
Florence, a New York-based provider of a healthcare enablement software platform, raised $20M in Seed funding
Series A Financing for AI-Based Life Sciences Procurement
Labviva announced that it secured $20 million in Series A financing. The Series A funding brings the total amount raised since inception to $30 million. The funding will accelerate the deployment of Labviva’s platform at several global pharmaceutical and academic customers.
Labviva provides an easy-to-use SaaS platform and marketplace that unifies the interface for product discovery and procurement and seamlessly connects suppliers and purchasers, allowing scientists to make better purchasing decisions. The company will also use the funding to expand its global footprint and launch new and complementary product lines.
Labviva provides a digital marketplace for life science companies and researchers by connecting them with reagents, chemicals, and instrumentation suppliers.
https://www.clinicalresearchnewsonline.com/news/2023/03/28/follow-the-money-university-of-utah-accelerates-heart-failure-gene-therapy-research-openclinica-s-cloud-technology-to-simplify-clinical-trials-more
Wellth reels in $20M to scale up its 'behavioral economics' approach to tackle chronic conditions
Los Angeles-based Wellth reeled in an oversubscribed series B fundraising round of $20 million led by SignalFire. The company has raised $40 million to date.
Wellth develops app-based digital health programs that use financial incentives and behavioral economics strategies combined with a consumer-grade smartphone experience to improve adherence to patients’ care plans.
Launched in 2014, the company's growth has been driven by its strong results and outcomes. Wellth’s health plan and provider clients have measured significant cost savings, and Medicare Advantage plans have achieved higher star ratings, according to CEO and co-founder Matt Loper.
The company plans to use the fresh capital to invest in the behavioral science engine behind the app and to grow its teams. Loper and co-founder and Chief Technology Officer Alec Zopf have their sights set on propelling Wellth to become a category-leading company.
https://www.fiercehealthcare.com/digital-health/wellth-reels-20m-scale-its-behavioral-economics-approach-tackle-chronic-conditionsZorro Steps Out of Stealth with $11.5M to Revolutionize Employee Health Benefits
Zorro, a pioneer in optimizing the health benefits experience for employees, employers and brokers, today announced its launch out of stealth, along with an $11.5 million seed funding round co-led by Pitango and 10D. The funds will be used to further expand R&D efforts and scale customer operations.
The process of offering employee benefits is complicated, opaque and burdensome. For employers and brokers, offering benefits often results in unpredictable budgets, endless administration, and a distraction from the core business. For employees, health benefits are generic and too often, completely out of their control.
Zorro's vision is to be the healthcare financial companion of the future by improving access to quality and affordable healthcare to millions of Americans. Zorro provides an end-to-end solution optimizing the employee, employer, and broker benefits experience. Its platform optimizes how to allocate employers' budgets, moving from a "one-size-fits-all" offering to a modular, personalized model for employees. Founded by Guy Ezekiel and Maya Perl, veteran executives in the healthcare and investment fields, Zorro was developed with a deep understanding of the US healthcare system and the needs of both employers and employees.
https://finance.yahoo.com/news/zorro-steps-stealth-11-5m-120000916.html?mc_cid=11ea4ca6cb&mc_eid=df5e82ed1d&guccounter=1